XML 74 R41.htm IDEA: XBRL DOCUMENT v3.25.1
Schedule of Deferred Tax Assets (Details) - USD ($)
Dec. 31, 2024
Dec. 31, 2023
Income Tax Disclosure [Abstract]    
U.S Federal and State net operating loss $ 3,083,545 $ 2,429,544
Stock based compensation 1,272,925 1,031,860
Accrued salaries 382,288 395,899
Orphan drug credit 1,060,118 924,171
Derivative liability 370,572
Other 260,481 392,486
Total net deferred tax assets 6,059,357 5,544,532
Valuation allowance (6,059,357) (5,544,532)
Total Deferred Tax Asset